Program Molecule Potential indications
SARM1 inhibition SIR2501 Neurodegenerative diseases
NAMPT activation SIR4156 Neuronal and muscular
degenerative diseases
RIPK1 inhibition SIR9900 Inflammation & Immunology
SIR2446 diseases, traumatic CNS conditions
Undisclosed SIR8752 Inflammation & Immunology diseases
Brain Delivery Module Therapeutic target / BDM Neurodegenerative diseases
Early-stage programs
  • Discovery
  • Lead   optimization
  • Preclinical development
  • Phase 1a
  • Phase 1b/2a
  • Late stage development